Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Y PEG-rhEPO in CKD-related anemia (hemodialysis) phase II
CTR20202413Phase 2Completed
- Sponsor
- Tebao Biotech
- Start
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of YPEG-rhEPO in anaemia, sponsored by Tebao Biotech. Started Nov 2020; status: completed.
02
Drugs
YPEG-rhEPO
03
Conditions
anaemia
Beyond the preview
Go deeper on CTR20202413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202413.